We're excited to provide UCB with the enterprise analytics solution that will enable their workforce to make decisions with greater speed and confidence.
Somerville, MA (PRWEB) January 29, 2007
Spotfire, Inc. (http://www.spotfire.com/), the Information Insight CompanySM, today announced that UCB, a global biopharmaceutical leader, has selected the Spotfire enterprise analytics platform. The Spotfire platform offers a radically faster business intelligence experience for business professionals and is far more adaptable to specific industry and business challenges than traditional business intelligence.
"Spotfire enables our business professionals to simultaneously visualize and interact with multiple sources of information with unprecedented ease, maximizing the potential of human insight and intuition. This is important in our UCB R&D environment," said Dr Melanie Lee, Executive Vice President, UCB. "We enjoy working with Spotfire and are looking forward to using their enterprise analytics platform."
For highly competitive businesses that win by rapidly discovering new insights in information, Spotfire offers an interactive, visual approach to data analysis that puts the power to ask and answer questions on demand directly into the hands of business users. The software goes beyond traditional business intelligence systems, arming business professionals with an easy-to-use, self-service environment where users can quickly discover new insights and address emerging threats.
"Today's business dynamics require that companies get more out of their data," said Christopher Ahlberg, CEO, Spotfire. "We're excited to provide UCB with the enterprise analytics solution that will enable their workforce to make decisions with greater speed and confidence."
Unlike current traditional business intelligence systems, the Spotfire Enterprise Analytic platform is architected to deliver a radically faster experience and one that is infinitely more adaptable to specific industry and business process analysis challenges and data sources. By delivering unparalleled user control, the Spotfire shifts the power to ask and answer virtually unconstrained questions to front line users, without requiring countless new reports or custom queries from IT. The new platform continues to gain rapid adoption across industries, including financial services, high tech manufacturing, energy and pharmaceutical.
Spotfire, the Information Insight CompanySM, is a leading provider of enterprise analytics software for next generation business intelligence. Spotfire software offers a visual and interactive experience that helps professionals quickly discover new and actionable insights in information. Distinguished by its speed to insight and adaptability to specific business challenges, Spotfire software rapidly reveals unseen threats and new opportunities, creating significant economic value. Spotfire's customers include industry leaders among the Global 2000 that have deployed Spotfire analytics to gain an information advantage over their competitors. For more information, visit http://www.spotfire.com.
UCB (http://www.ucb-group.com) is a leading global biopharmaceutical company dedicated to the research, development and commercialisation of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology - UCB focuses on securing a leading position in severe disease categories. Employing over 8,300 people in over 40 countries, UCB achieved revenue of 2.3 billion euro in 2005. UCB is listed on the Euronext Brussels Exchange. Worldwide headquarters are located in Brussels, Belgium.
Spotfire, DecisionSite and Spotfire DXP are trademarks or registered trademarks of Spotfire, Inc., except in the European Community where Spotfire and the products listed are trademarks of Spotfire AB. Other company or product names may be the trademarks of their respective owners.